FoundationOne CDx

1 product

6 abstracts

3 targets

Target
TMB
Target
ERBB2
Target
HER2
Abstract
CUPCOMP: A multi-site UK trial in carcinoma of unknown primary: A comparison across tissue and liquid biomarkers.
Org: Cancer Research UK National Biomarker Centre, Royal United Hospitals Bath NHS Foundation Trust, Torbay and South Devon NHS Foundation Trust, Velindre University NHS Trust, Clatterbridge Centre for Oncology NHS Foundation Trust,
Abstract
Actionability of comprehensive genomic profiling compared to the tissue-based and plasma-based assay in patients with metastatic breast cancer: A real-world study.
Org: Department of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Tohoku University Hospital, Miyagi Cancer Center, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Tohoku University Graduated School of Medcine,
Abstract
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.
Org: Mount Sinai Health System, SWOG Statistics and Data Management Center, Seattle, WA, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Dana-Farber Cancer Institute, SWOG Statistical Center,
Abstract
Turnaround time of tissue next generation sequencing in cancer patients at a safety net hospital: A quality improvement project.
Org: Perlmutter Cancer Center at NYU Langone Health Medical Center, NYU Langone Health, New York, NY, NYU Grossman School of Medicine, Department of Population Health,